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Available online 20 February 2008Synaptic vesicles are central to neurotransmission and cognition. Studies of the Alzheimer's disease (AD)
associated peptide, amyloid beta (Aβ), suggest that it has the potential to non-speciﬁcally solubilize or
permeabilize membranes and that it has detergent and pore-forming properties. Damage to the membrane or
integrityof synaptic vesicles could compromise its function.We test thehypothesis that the intact synaptic vesicle
is a direct site of attack by Aβ1–42 in AD pathology by examining the properties of individual isolated vesicles
exposed to Aβ1–42. Inparticular, we compared the rate of leakage of dyemolecules from synaptic vesicles, the rate
of proton permeation across the membrane of the vesicle, and the rate of active proton transport into the vesicle
interior in the presence and absence of Aβ1–42. From these experiments, we conclude that isolated synaptic
vesicles are not disrupted by Aβ1–42.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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Synaptic vesicles (SVs) are nano-scale membranous compartments
whose function is central to neurotransmission and cognition. Commu-
nication between neurons is mediated by the quantal release of
neurotransmitters from individual SVs thatmeasure ~40 nm in diameter.
Therefore, the correct activity of SVs is prerequisite for brain function [1].
To do their work of concentrating and storing neurotransmitters in
preparation for release, SVs generate andmaintainpHgradients aswell as
electrical potential gradients [2]. Any interferenceof thenormal activityof
SVs has profound effects on synaptic function. For example, Levetirace-
tam, an anti-epileptic drug, has a dramatic effect onbrain activity through
interactions with SV2 (Synaptic Vesicle Protein 2), an integral membrane
protein embedded in the SV membrane [3]. The SV is thus an important
subject of study in the quest to understand proper brain function as well
as the pathology of diseases of the central nervous system.
Alzheimer's disease (AD) is the debilitating neurodegenerative
disease that causes age related loss of cognitive function. Recentﬁndings
strongly suggest that thepathology is synapse-related [4]. The formation
of widespread amyloid tangles or plaques in the brain is a hallmark of
the disease, and has been widely explored in its relation to disease
progression [5]. The plaques are composed primarily of aggregates of
peptide fragments, including amyloid beta 1–42 (Aβ1–42). Although the
plaques are dramatic and visible, the presence of unaggregated, soluble
Aβ tracks the disease symptoms much more closely than does the
formation of plaques [6]. The reigning disease model is that AD pathol-
ogy is mostly the result of a combination of known and unknown
effects of this soluble Aβ [7,8]. In terms of high afﬁnity protein–proteiniu).
ll rights reserved.interactions, it has been shown recently that Aβ1–42 can bind to α7
nicotinic acetylcholine receptor (α7-NR) with picomolar afﬁnity [9] and
can activate neurons and cause Ca2+ inﬂux via the mitogen-activated
protein kinase cascade [10]. Furthermore, α7-NR is known to modulate
glutamate receptors [11], and levels of NMDA glutamate receptors at the
synapse have been shown to decrease with application of Aβ1–42. This
decrease may be caused by lateral movement of the α7-NR and NMDA
receptors away from the synapse or by endocytosis [12]. The most
accepted view of AD is that interactions such as these cause cellular
changes that culminate in synapse dysfunction and neuronal death in a
manner related to an increase in intracellular calcium.Most studies have
focused on extracellular Aβ, but there are a number of studies [13–16]
that have implicated intracellular Aβ as one possible factor in AD
pathology. In addition to high toxicity [17], disruption of intracellular
calcium stores or direct disruption of organelle function could result
from the presence of intracellular Aβ.
Besides such protein–protein interactions thatmay indirectly cause
calcium deregulation, this complicated peptide has detergent-like [18]
and pore-forming properties [19]. Studies of Aβ suggest that it has the
potential to solubilize or permeablize membranes through its lipid-
binding properties [20]. In vitro, SVs can be destabilized with
detergents [21]. Indeed, this is a common method for preparing SV
proteins for biochemical analysis. Likewise, pores would be proble-
matic for the maintenance of the gradients on which SV function
depends. Because Aβ and SVs are present in close proximity at the
synapse in AD affected brains [22] and VGLUT1, a vesicle-speciﬁc
neurotransmitter transporter, is reduced in concentration in regions of
AD brains [23], it is hypothesized that Aβ might directly affect the
integrity of SVs. Because SVs are the critical components that mediate
interneuronal communication, and because it has membranes and
a number of proteins that are all subject to potentially problematic
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particularly vulnerable to attack by Aβ.
Here we tested the hypothesis that the intact SV might be a site of
non-speciﬁc attack by Aβ1–42 in AD pathology, owing to the detergent-
like properties of Aβ1–42, the fragment with the lowest CMC (critical
micelle concentration) [24] and the highest toxicity [22,25]. We used
isolated synaptic vesicles to ensure we are studying the direct effect of
Aβ1–42 on synaptic vesicles rather than the indirect effects caused by
interactions with other non-vesicular synaptic proteins. Speciﬁcally,
we studied the effects of Aβ1–42 on the integrity, permeability, and
functionality of isolated, individual SVs [26]. To monitor individual
vesicles with sub second time resolution in parallel, we used a laminar
boundary steering ﬂow cell and total internal reﬂection ﬂuorescence
(TIRF) microscopy. We observed the effects of Aβ1–42 on the leakage
rate of an associated small-molecule dye, Oregon Green, as well as the
leakage rate of H+ from the extravesicular solution into the lumen of
the vesicle as monitored with the pH sensitive GFP, pHluorin. In
addition to the analysis of the attributes of SVs from a physio-chemical
perspective, we studied the biological activity of SVs as measured by
their ability to pump protons into the vesicles via the H+/ATPase.
Counter to our expectation, our results show that Aβ1–42 causes no
observable injurious change to SV permeability, integrity, or activity.
2. Materials and methods
2.1. Vesicle isolation
Rat brains were obtained frozen from Pel-freeze biologicals (Rogers, AK). Mouse
brains from transgenic mice expressing the pH sensitive GFP-VAMP fusion proteinwere
obtained from the Bajjalieh laboratory; the strain originated in the Murthy laboratory
[27]. Vesicles were puriﬁed by density centrifugation as described elsewhere [26].
Brieﬂy, brain matter was frozen in liquid nitrogen then reduced to a powder with a
Waring blender. The resulting powder was placed into homogenization buffer: 50 mM
HEPES (USB corporation, Cleveland OH), 2 mM EGTA, .3 M Sucrose (J.T. Baker,
Phillipsburg, PA) adjusted to pH 7.2. This slurry was placed into a homogenizer and 10
passes weremadewith the rotating pestle. The homogenatewas spun at 37,000 rpm for
28 min in a Beckman Optima Max E centrifuge and the supernatant was collected. The
supernatant was ﬂoated on the top of a sucrose step gradient consisting of 1.5 M and
.6 M sucrose in 50 mM HEPES at pH 7.2. This was spun at 59,000 rpm for 72 min. The
vesicles settled on top of the 1.5 M sucrose cushion; they were extracted with a Pasteur
pipette and frozen in liquid nitrogen in 50 μl aliquots and stored at − 80 °C.
2.2. Microﬂuidic chip fabrication
Microﬂuidic channels were fabricated in Poly(dimethylsiloxane) (PDMS) and has
been described extensively elsewhere [28]. We ﬁrst designed our chip in Macromedia
Freehand then printed the design on a transparency using a commercial imagesetter.
The resulting mask was used to direct UV light to regions of spin-coated SU-8-2050
photoresist (Microchem, Newton, MA) on a silicon wafer, which was subsequently
developed per manufacturer speciﬁcations. The resulting features were used as a
positive master for molding PDMS (Dow Corning, Midland, MI). Inlet and outlet holes
were punched in the polymer slab using a cork borer. To form the glass coverslip ﬂoor of
themicrochannels, Corning brand number 1 coverslips were ﬁrst cleaned by boiling in a
3:2:1 mixture of water, ammonium hydroxide and (30%) hydrogen peroxide. The
punched PDMS slabs and cleaned glass were placed in an oxygen plasma for 2min, after
which the glass was sealed to the PDMS slab. The resulting chip was placed in a
desiccator with 2-[methoxy(polyethyleneoxy)propyl]trimethoxy-silane (Gelest, Mor-
risville, PA) and a vacuum was applied for 3 min or until bubbles formed in the silane
liquid. The silane was allowed to react with the chip surface for 2–3 h.
2.3. Antibody labeling and two-color TIRF imaging of synaptic vesicles
Mouse antibodies against synaptophysin were acquired from Chemicon Interna-
tional (Temecula, CA) and were labeled with Invitrogen's (Eugene, OR) Zenon 647
labeling system per manufacturer's instructions; this produced ﬂuorescent antibodies
labeled with Alexa 647. To remove sucrose prior to labeling of synaptic vesicles with
antibodies, the vesicle solution was diluted ten fold into 10 mM HEPES buffer (with
150 mM–KCl at pH 7.2) and re-concentrated three times using a Vivaspin concentrator
with a molecular weight cutoff of 1 MDa (Vivascience AG, Hannover, Germany). The
vesicles were then exposed to the solution with dye-tagged antibodies for 10 min,
following which they were puriﬁed using a Sephacryl S-500 size exclusion spin column
(Amersham Biosciences, Uppsala, Sweden).
The vesicles were viewed using a home-built TIRF microscope (Nikon TE2000; 60×
objective with a numerical aperture of 1.45) equipped with 488 nm (Coherent Sapphire
laser) and 633 nm (Coherent HeNe laser) illumination. The sample was illuminatedsimultaneously with both excitation wavelengths, and ﬂuorescence was collected and
split into two color channels to allow for simultaneous acquisition of the red and green
ﬂuorescence signal. The two-color images were recorded with a PhotonMax EMCCD
camera (Princeton Instruments, Trenton, NJ), then aligned and overlaid with software
written in-house.
2.3.1. Monitoring the leakage of OG from synaptic vesicles
Prior to imaging, rat vesicles were diluted 1:1 into pH 7.2 HEPES buffer (10 mM
HEPES and 150 mM KCl) containing 10 µm Aβ1–42 (American Peptide, Sunnyvale, CA)
that was aged 48 h [29] at room temperature. Studies of Aβ1–42 suggest that its toxicity
and pore forming abilities correlate with secondary structure as measured by circular
dichroism (CD). We measured the CD spectrum of aged Aβ1–42 prepared as that for our
experiments and found it to correlate well to that of the toxic form presented by
Simmons et al. [29] at the relevant wavelengths. These vesicles were allowed to
incubate with Aβ1–42 for 10 min, and were then introduced into the chip and loaded
with OG as described above. In preliminary experiments, lack of discernable changes of
SVs exposed to Aβ without any prior incubation led us to include an incubation time.
We chose our particular incubation time as it was on the order of magnitude chosen by
Lin et al. [30] for the formation of pores in synthetic liposomes balanced against the
desire to maximize the freshness of vesicles for optimal OG uptake. After loading for
60 s, OG load buffer was ﬂushed out of the channel with pH 7.2 HEPES buffered 150 mM
KCl containing 5 µm Aβ1–42. Leakage of OG from synaptic vesicles was observed under
TIRF microscopy. We address photobleaching by comparing constant illumination to
shuttered illumination with a range of shuttered delay times between frames. The
results showed that with long, shuttered delay times (1 acquisition every 10 s) photo-
bleaching is minimized and represents only a few percent of the measured rate. While
these few percent may be relevant for a quantitative study of the rates, it does not affect
the conclusions based on the comparison of two datasets that implicitly take into
account this small background ﬂuorescence loss. The illumination power was limited to
50 μW. Using software developed in-house, diffraction-limited spots in the ﬁrst frame
with a signal-to-noise ratio of greater than 5 were selected and tracked through
subsequent frames, so an intensity-versus-time trace could be constructed for each
vesicle.
2.3.2. Western blot assay of Aβ1–42
We aged Aβ1–42 samples for 48 h in deionized water equivalently to that which was
applied to the SVs; we also aged a sample in HEPES buffered KCl equivalent to the buffer
applied to the vesicles. We ran polyacrylamide gel electrophoresis of these samples in
TRIS/Glycine bufferwith .1% SDS using standard protocols.Weutilized ReadyGel pre cast
polyacrylamide gels (12%, Bio-Rad Hercules, CA) according to manufacturer's instruc-
tions, including the formulation of sample buffer containing beta-mercaptoethanol. We
included biotin-functionalized protein size standards (Bio-Rad, Hercules, CA).
After separation, we electro-blotted onto a nitrocellulose membrane using the
Trans Blot electrophoretic transfer cell apparatus (Bio-Rad, Hercules, CA) according to
manufacturer's instructions with the exception of the blocking agent for which we
substituted SuperBlock (Pierce, Rockford, IL). We immunolabeled the membrane with
monoclonal mouse antibodies raised against Aβ residues 1–16 (clone 6E10, Biosource).
We labeled the protein size standard with blotting grade avidin linked HRP (Bio-Rad,
Hercules, CA). We visualized the result using the Supersignal chemiluminescent
detection kit, which included horseradish peroxidase linked secondary antibodies
(Pierce, Rockford, IL). The chemiluminescence was recorded with a Kodak gel imager
(Imagestation 440 CF, Kodak, New Haven, CT).
2.4. Monitoring proton permeation into synaptic vesicles
To follow proton permeation into synaptic vesicles, we used SVs from transgenic
mice expressing the synaptopHluorin construct [27]. We incubated the vesicles with
5 µM aged Aβ1–42 in pH 7.2 HEPES buffer (10 mM HEPES and 300 mM Sucrose) for
20 min. After the vesicles were loaded into the microchannel, pH 6.5 HEPES buffer with
300 mM sucrose was ﬂushed through the channel and the vesicles were observed with
TIRF microscopy as previously described but with illumination power increased to
1 mW. Sequential images were collected at 100 ms integration per frame.
2.4.1. Monitoring active transport of H+ into synaptic vesicles
Similar to the procedure described above, we diluted (1:1) the vesicle solution in
pH 7.2 HEPES buffer (10 mM HEPES, 300 mM sucrose) containing 10 µM Aβ1–42
(American Peptide) that was aged 48 h [29]. Aβ1–42 was diluted from a 1 mM stock
solution in DMSO (ﬁnal concentration was 5 µM Aβ1–42 with .5% DMSO); the same
concentration of DMSO was present also in our control experiments. These vesicles
were allowed to incubate 20 min and then were loaded into the chip. The channel was
then ﬂushed with glutamate loading buffer (.3 M sucrose, 10 mMHEPES pH7, 4 mM KCl,
10 mM ATP, 4 mM MgSO4) and the vesicles were immediately observed by TIRF
microscopy. Sequential images were collected at 100 ms integration time using a liquid
crystal shutter to minimize light exposure between frames.
2.4.2. Monitoring vesicle disruption due to surfactant
To ensure our technique can detect the sort of disruption events we hypothesized,
we performed control experiments using surfactants that are known to disrupt synaptic
vesicles. Here, we observed the effects of surfactants to be dramatic and rapid, and to
effectively record them, we utilized computer control. Brieﬂy, we built a PC controlled
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Instruments, Austin, TX). This device applied pressure to a microﬂuidic channel system
in order to drive ﬂuid across the region of observation at a speciﬁed time. Under
computer control, we maintained the focus of the microscope using a piezoelectric
sample stage with feedback control from a commercial closed-loop positioning system
(ASI corporation, Eugene, OR). We performed two experiments of this kind.
In the ﬁrst experiment, we applied Triton X-100 (Fisher Biotech Fairlawn, NJ) to
vesicles loaded with Oregon green. The sequence of events went as follows: the glass
was exposed to cleaning solution (.1 M NaOH and .1% SDS) for 5 s. The channel was then
rinsed with HEPES buffer (.15 M KCl and 50 mM HEPES at pH 7.2). Vesicles in their
original isolation buffer (see section 2.1) were then passed over the glass and some
adhered over the course of 5 s. These vesicleswere then exposed to aﬂowof 5 μMOregon
Green in 50 mM Citrate buffer with .15 M KCl at pH 5.2 for 8 s. The surface was then
illuminated in TIRF mode and the vesicles observed in either HEPES buffer or HEPES
buffer containing Triton X-100 at various concentrations, of which 17 μM (10− 3% v/v)
gave a subtle but discernable change over the observation period of ~60 s.
In the second experiment, we used pHluorin vesicles and a simpliﬁed procedure.
We exposed the glass to vesicles for 2 s and then clear HEPES buffer. We used TIRF
illumination and started data acquisition. We then applied strong base and surfactant
solution (0.1% SDS and 0.1 M NaOH) and observed the response.Fig. 1. (A) A schematic of the experimental setup; insets to the right of the schematic are TIRF
OG ﬂuid stream occupied the bulk of the main channel) and after loading (bottom image; he
(B–G) Schematic illustrating the procedure we used for loading vesicles with OG; similar
exchange the solution around vesicles. (B) A suspension containing synaptic vesicles was in
(C) Buffer solution from the top inlet was induced to ﬂow and perfuse the main channel. (D)
ﬂow boundary between the buffer and OG ﬂuid stream. (E) Pressure to the OG streamwas inc
occupying the bulk of the main channel (this step corresponds to the top image in (A)). (F an
the main channel as well as the bottom channel (which corresponds to the bottom image i3. Results
3.1. Microﬂuidic perfusion system, TIRF microscopy, and loading of
synaptic vesicles with Oregon Green
We used a microﬂuidic perfusion chip to exchange the solution
surrounding the vesicles rapidly and efﬁciently. Fig.1 is a schematic that
shows our experimental approach. The surface of the glass coverslip
formed the ﬂoor of the microﬂuidic channel. Prior to use, this glass
surface was ﬁrst coated with polyethylene glycol, to which SVs spon-
taneously adhered. To exchange the solution around the immobilized
vesicles, we used laminar ﬂow switching, in which pressure from the
two inlets to themicroﬂuidic ﬂow channel was differentially modulated
to steer the laminar boundary between the two ﬂuid streams. Fig. 1B–G
schematically shows this procedure. We used gravity driven ﬂow, in
which the ﬂow rate of each streamwas determined by the height of theimages that show vesicles during the loading of Oregon Green (OG) (top image; note the
re the buffer stream completely displaced the OG stream). Scale bar represents 100 μm.
procedure was used in other experiments to steer the laminar-ﬂow boundary and to
troduced into the main channel from the outlet well (arrow indicates direction of low).
Solution containing OG was ﬂown from the bottom inlet, which established a laminar-
reased slightly, which displaced most of the buffer stream and resulted in the OG stream
d G) After loading, pressure to the top inlet was increased so the buffer stream perfused
n (A)).
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inlet wells, we increase the gravity pressure from that well with respect
to the other well. This relative increase in pressure causes a relative
increase in the ﬂow rate in the corresponding inlet channel, which
displaces the laminar boundary from the fast ﬂuid stream towards the
slow ﬂuid stream. By balancing these pressures using a home-built
microinjector [31] with a slight bias to one or the other inlet well, we
were able to steer the laminar boundary precisely between the twoﬂuid
streams in the channel. This method permitted fast ﬂuid exchange so
that once vesicles were introduced to the system and they had adhered
to the surface, their environment could be quickly changed from neutral
pH to acidic pH or from dyed to clear buffer.
To image the surface-bound vesicles, we used TIRF microscopy,
where an evanescent wave was set up by total-internal reﬂection
along the glass–aqueous interface so only the ﬁrst couple hundred
nanometers from the surface was illuminated. The small size of the
vesicle (~40 nm in diameter) ensured that it lied within the thin
evanescent-wave layer and was being excited efﬁciently. This optical
arrangement allowed us to study individual vesicles with good signal-
to-noise. To probe themembrane integrity of SVs, we followed the rate
of leakage of a small molecule dye, Oregon Green (OG), from indi-
vidual synaptic vesicles in a physiological buffer. Prior to this leakage
study, we had to load the vesicles with OG, which consisted of the
following steps: (1) A suspension containing SVs (HEPES buffer at pH 7
with 150 mM KCl) was introduced into the chip (Fig. 1B); after waiting
for a few seconds to allow for the vesicles to adhere to the surface, theFig. 2. Co-localization studies of vesicles loadedwithOregonGreen (OG) and taggedwith antib
shows the red-channel ﬂuorescence, which were from Alexa 647 labeled secondary antibodi
the Oregon Green loaded vesicles, which ﬂuoresce in the green channel. Right column (C, F,
channel is localized to the same vesicles. Scale bar represents 5 µm.suspensionwas ﬂushed out of the chipwithwash buffer (HEPES buffer
with 150 mM KCl) (Fig. 1C). No vesicles were visible at this stage as
they were not ﬂuorescent. (2) Under laminar ﬂow, a loading solution
(citrate buffer at pH 5 with 150 mM KCl) containing 5 µM OG was
introduced into the channel such that a laminar boundary was
established between the wash buffer and the loading solution in the
channel (Fig. 1D and E). The vesicles were allowed to load with OG for
60 s (Fig. 1F). (3) After loading, the relative pressure at the two inlets
was immediately adjusted so that the wash buffer displaced the
loading solution in the channel (Fig. 1G). Here the vesicles were
ﬂuorescent and visible as they have now been loaded with OG. This
procedure avoids any contamination of the wash buffer and offers
precise control over the timing of the ﬂuid exchange with respect to
the SVs.
We have at least two reasons to believe that OG was internalized
into the SVs rather than adsorbed onto the surface of the vesicles. First
is the issue of surface coverage and density: by comparing the
ﬂuorescent intensity from single OG and the OG loaded SVs, we
estimated there were several thousand OG molecules per vesicle. For
simplicity, if we take a SV to be 40 nm in diameter (from electron
microscopy measurements, SVs were estimated to range in diameter
from 34–44 nm [1]), it will have 5000 nm2 in surface area to accom-
modate the OG molecules. At several thousand OG molecules, this
surface would be mostly covered to the extent that the dyes should
exhibit self-quenching, which we did not observe. Second, we were
only able to load OG into SVs at pH 5 and the loading effect is entirelyodies against synaptophysin, a synaptic-vesiclemembrane protein. Left column (A, D, G)
es bound to the primary antibody against synaptophysin. Middle column (B, E, H) shows
I) are the two-color overlaid images, which show ﬂuorescence from the green and red
330 P.B. Allen, D.T. Chiu / Biochimica et Biophysica Acta 1782 (2008) 326–334absent at pH 7. However, after SVs have been loaded at pH 5, the rate at
which OGmolecules leak from the SVs is similar between pH 5 and pH
7. Therefore, if the OG molecules were surface associated after loading
at pH 5, then we would expect a rapid dissociation of any surface
bound OG upon exchanging the external solution to pH 7. The absence
of a rapid loss of OG indicates internalization of OG to the vesicle
interior. Although the mechanism of internalization remains unclear,
changes to internal vesicle structure due to environmental changes
have been noted in the literature [32]. To understand this phenom-
enon, we performed a number of exploratory experiments.We treated
the vesicles with chloride channel and glutamate transporter poisons
(5-nitro-2-(3-phenylpropylamino) benzoic acid, niﬂumic acid, Evans
blue) and ATPase poisons (sodium azide, baﬁlomycin) all without
effect (data not shown). Because the pH at which Oregon Green loads
(pH 5.2) is nearly the same as the pKa of the dye, we hypothesized
that, when protonated, it was able to cross themembrane. This may be
true, and may account for its relatively fast leakage. However, carboxy
ﬂuorescein does not associate with SVs at its pKa. Oregon Green is di-
ﬂuorinated ﬂuorescein and so its structure is quite similar. Evidently
something aside from the protonation state of the dye is at work.
To show that these ﬂuorescent objects are indeed SVs loaded with
OG, we performed immunolabeling of the vesicles with a primary
antibody against synaptophysin (a SV speciﬁc integral membrane
protein) and a secondary antibody labeled with the far-red Alexa 647
dye. Fig. 2 presents typical images that show the overlay of the green
(middle column) and red (left column) ﬂuorescence channel, inwhichFig. 3. Comparison of the rate of leakage of Oregon Green (OG) from isolated synaptic vesicles
to the presence of OG, but lost their ﬂuorescence over time as OG leaked from the vesicles. (
continuous line is the exponential function towhich the data were ﬁtted. The bar graphs to th
measurements. The upper inset (bar graph) shows the average half life of Oregon Green lea
experiment, the vesicles were illuminated continuously and a frame captured every 0.1 s. (B)
bars are from the control experiments and the light bars are from the Aβ1–42 treated vesicle
vesicles in the presence of buffer or buffer spiked with Aβ1–42. In this particular experimeneach green spot that corresponded to an OG-loaded synaptic vesicle is
overlaid (right column) with a red spot caused by speciﬁc antibody
labeling. From this co-localization study and the known purity of the
SV preparation [26], we are conﬁdent that each green spot was indeed
a loaded synaptic vesicle.
3.2. Quantifying OG dissociation from SVs
After loading SVs with OG, we followed the rate of OG leakage from
SVs in the presence and absence of 5 µM Aβ1–42. Typical Aβ1–42
concentrations at which cell cultures show toxic effects are in the
100 nM range [33], but the concentration at which Aβ1–42 is toxic
within the cytoplasm (where it would encounter SVs) is below 1 nM
[17]. Given the known presence of toxicity at low concentrations, if
there is no effect on SVs at this high concentration of 5 µM, it seems
safe to assume that other toxic pathways will dominate. To minimize
photobleaching of SVs, we shuttered our illumination so the vesicles
were excited every 9 s for a duration of 1 s at a low laser power of
50 µW. We analyzed the ﬂuorescence from vesicles with an in-house
developed software where we required all ﬂuorescent spots we
analyzed to be sharp, that is, all neighboring pixel intensities should
be less than 75% of the pixel with the peak value. This requirement
ensured that we were following ﬂuorescent spots that were sub-
diffraction limited, consistent with the small size of the SVs.
The result of our image analysis was a series of time-intensity
traces, where each trace corresponded to the ﬂuorescence decay rate,in the presence and absence of Aβ1–42. Synaptic vesicles were ﬂuorescent initially owing
A) Averaged rate of leakage; the dotted points are experimental measurements and the
e right show the average half-life; the error bars represent the standard deviation of the
king from vesicles in the presence of buffer or buffer spiked with Triton X-100. In this
Histogram showing the distribution of half-life among single synaptic vesicles. The dark
s. The lower inset (bar graph) shows the average half life of Oregon Green leaking from
t, the vesicles were illuminated every 10 s for 1 s.
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the results of adding high and low concentrations of detergents to the
vesicles under ﬂow conditions and observed complete disruption of
the immobilized vesicleswithin one 100-ms frameof our acquisition at
high concentrations and a markedly faster leakage of OG in dilute
conditions. These time-intensity traces for the Aβ1–42 experimental
and control cases were then ﬁtted to an exponential decay curve to
arrive at a value for the leakage half-life of each vesicle. Fig. 3 sum-
marizes our measurements, where the average half-life of OG leakage
in the presence and absence of Aβ1–42 is comparable. We are using the
leakage rate of OG as an indicator of the integrity of the membrane of
SVs. With this metric, we conclude that Aβ1–42 does not adversely
affect the permeability of SVs. The bottom inset of Fig. 3 shows the
average decay half life; the error bars represent the standard deviation
of our measurements.
This result stands in contrast to the top inset, which shows the half
life change due to the addition of TritonX-100 at a dilute concentration
of 17 μM or 10− 3% (v/v). The time traces of individual vesicles exposed
to Triton X-100 were processed in the same way as the amyloid beta
case described above. The “control” decay half life shown in this case
wasHEPES buffer,whichwas the same as for the amyloid beta case. The
difference in the absolute decay rate between the Triton X-100 case
and the Aβ1–42 case is due to the different acquisition rates; at higher
acquisition rates where the vesicles were illuminated more frequently
and (to compensate for shorter integration time) at a higher intensity,
photobleaching was proportionally faster and thus resulted in a faster
decay rate. This control serves two purposes: it shows that we canFig. 4. Comparison of the rate of H+ permeation across themembrane of synaptic vesicles in th
was used as the pH indicator inside the vesicles. Initially vesicles were ﬂuorescent because t
was lowered to 6.5 and as H+ entered the vesicles the ﬂuorescence was quenched. (A) Averag
the sigmoidal function to which the data were ﬁtted. From the ﬁt, we extracted the maxim
maximal permeation rate) was plotted on the right; the error bars represent the standard dev
of H+ permeation (best-ﬁt maximal slope) among single synaptic vesicles. The dark bars are f
inset to the right of the histogram shows the result of a western blot assay of the preparatidetect a small changewith our experimental setup and procedure, and
that low concentrations of surfactant can cause this increased leakage
rate. The effective normalized half life due to surfactant (i.e. after
accounting for other decaymechanisms present in the control, such as
photobleaching) is approximately 2 s. Aβ1–42, in contrast, does not
cause any discernible increase in the decay rate even overmuch longer
time scales (60 s).
The bottom inset of Fig. 4 shows the result of awestern blot assay of
the Aβ1–42 preparation with immunohistochemical and chemilumi-
nescent detection. The molecular weight proﬁle was reasonably
consistent with results published by Stine et al.[34] for preparations
shown to contain oligomers. At 14 kDa, there is a feature that is likely
the unresolved monomer and dimer bands, followed by features at
higher molecular weights (31–66 kDa) that are indicative of the
presence of oligomers [36]. The effect showed no qualitative difference
when we ran preliminary experiments in buffered sucrose or at other
pH values (data not shown). Leakage rates for various neurotransmit-
ters from SVs are anecdotally reported to have a wide range. It is
reasonable to think that the leakage half-life of many minutes may be
roughly comparable to that of other small molecules like neurotrans-
mitters given the results fromRyan and coworkers [35], which suggest
that a vesicle can undergo a complete cycle in approximately 30 s.
3.3. Quantifying pH change of individual synaptopHluorin SVs
In addition to using the leakage rate of OG as a measure of vesicle
permeability, we also measured the permeability of protons across thee absence and presence of Aβ1–42. A pH sensitive GFP (pHluorin) fused to synaptobrevin
he pH inside and outside the vesicles was equilibrated at pH 7.2, but as the external pH
ed rate of ﬂuorescence quenching; the dotted points are data and the continuous line is
al rate or slope of ﬂuorescence decrease. The average maximal slope (i.e. the average
iation of the measurements. (B) Histogram showing the distribution of themaximal rate
rom the control experiments and the light bars are from the Aβ1–42 treated vesicles. The
on of Aβ1–42.
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localized to the lumen of the vesicle as a reporter of intravesicular pH;
this pHluorin molecule is fused with the synaptic vesicle protein,
synaptobrevin (VampII) [27]. In our experiments, the intravesicular
pH was neutral (pH 7.2) because it was equilibrated with the external
buffer solution at pH 7.2. Under this condition, the pHluorinmolecules
were ﬂuorescent. When the external buffer solution was suddenly
changed to acidic (pH 6.5), protons began to permeate the membrane
and enter the vesicle to quench the pHluorin ﬂuorescence. The rate of
ﬂuorescence quenching in response to the sudden drop in external pH
is thus another metric of membrane permeability [36,37].
We measured this ﬂuorescence quenching in the same manner as
described above, with the exception that we used the sigmoidal
function, y = h/(1 + e(kx + o)), to ﬁt the quench curve, because the rate of
pH change is not only proportional to the difference between the
internal and external pH but also to the extent of deprotonation of the
buffering moieties within the vesicle. The time constant (k) we
extracted from the ﬁt corresponds to the maximal slope of the ﬁt line.
Fig. 4 summarizes our results; the difference in the time constants in
the absence and presence of Aβ1–42 is again comparable, indicating the
membrane of SVs was not adversely affected or solubilized by the
detergent properties reported for Aβ [18,20].
3.4. Auto-acidiﬁcation rate of SVs
In vivo, the SV auto-acidiﬁes using energy derived from the
hydrolysis of ATP. The model of SV function is that energy from ATP
hydrolysis is converted to a membrane H+ gradient and electrochemi-Fig. 5. Comparison of the rate of ATP driven auto-acidiﬁcation of synaptic vesicles in the ab
actively pumped into the vesicle via the H+/ATPase, thereby quenching the ﬂuorescence fro
points are experimental measurements and the continuous line is the exponential function to
behavior of pHluorin vesicles exposed to surfactant (0.1% SDS) and base (0.1 M NaOH). The
external pH, followed by a loss of ﬂuorescence caused by the disruption of the vesicles. (B) H
bars are from the control experiments and the light bars are from the Aβ1–42 treated vesicles.
error bars represent the standard deviation of the measurements.cal potential, which are ultimately utilized by the membrane
neurotransmitter transporter to ﬁll the vesicle with concentrated
neurotransmitters. In synaptopHluorin vesicles, the establishment of
membrane proton gradient quenches the internal pHluorin ﬂuores-
cence. The quenching of synaptopHluorin is therefore a metric of the
proton transport behavior of SVs [27]. We measured the rate of
acidiﬁcation of individual vesicles when exposed to ATP, magnesium,
glutamate and chloride in aHEPES buffer. In contrast to the experiment
discussed above, the pH of the solution outside the vesicle was neutral
(pH 7.2), rather than acidic at pH 6.5, because here we are studying the
ATP dependent activity of the H+/ATPase on the SVs. This rate of
acidiﬁcation did not change signiﬁcantly in the presence of Aβ1–42
(Fig. 5). Presumably, if SVs were signiﬁcantly more permeable to H+
after exposure to Aβ1–42, it would fail to acidify, or show a decreased
rate of auto-acidiﬁcation. Fig. 5A shows an average time trace of a
representative auto acidiﬁcation experiment. Fig. 5B shows the
histogram while the inset shows the average of all individual auto
acidiﬁcation rates with and without Aβ1–42.
The inset in Fig. 5A is a time-series that illustrates our ability to
discern changes in the vesicles due to changes in their environment,
and speciﬁcally surfactant induced disruption of the vesicles. The inset
plots the average behavior of synaptic vesicles in response to the
introduction of surfactant (0.1% SDS and 0.1MNaOH). The introduction
of surfactant and exchange of extravesicular solution was initiated by
computer controlled pressure-driven ﬂow, which is marked as time
zero on the x-axis and at which point an increase in ﬂuorescence can
be seen as the pHluorin were de-quenched (because of the basic pH)
and then a drop of virtually all ﬂuorescence within one image framesence and presence of Aβ1–42. Although the external pH was neutral (pH 7.2), H+ was
m pHluorin. (A) Averaged rate of ﬂuorescence quenching and H+ transport; the dotted
which the data were ﬁtted. The inset to the right of the decay curve shows the averaged
pattern includes a spike in ﬂuorescence as the pHluorin was de-quenched by the high
istogram showing the distribution of half-life among single synaptic vesicles. The dark
The bar graph to the right of the histogram shows the average half-life of quenching; the
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as anticipated and that the experimental apparatus is capable of
detecting these changes. The lack of any discernible change in the
vesicles' behavior in response to prolonged exposure to Aβ1–42 lends
further support to our ﬁnding that there is little or no direct effect of
Aβ1–42 on the membrane integrity of SVs.
4. Discussion
Despite the small size (~40 nm) of synaptic vesicles, they are
complex (with tens of different types of embedded and associated
proteins) and they occupy the central role in neurotransmission. This
paper describes a simple and versatile platform for studying single
synaptic vesicles. Precise steering of laminar ﬂows permits the rapid
and complete solution exchange around vesicles, and TIRF imaging
allows single-vesicle data to be collected simultaneously for a popu-
lation of vesicles. We applied this method to study the effect of Aβ1–42
on isolated synaptic vesicles. Themany states and possible interactions
displayed by the peptide Aβ belie its small size. It has been shown to
interact as aggregates [38], and has been seen to interact with lipid
bilayers [20] and a host of different proteins [8] with various strengths
that do not necessarily correlate with measured toxicities. It has been
localized intracellularly [16] and extracellularly in plaques and tangles
that are diagnostic for the disease [5,39] and has been shown to be
toxic to varying degrees in both cases. Although progress towards
treatment continues [40], any number of these interactions may play
roles in AD pathology to varying degrees and at different stages of the
disease progression. Exploring and characterizing the many possible
avenues that Aβmay impact neuronal and synapse function as well as
survival is of great importance in understanding the nuances of this
complicated disease. Our preparation of aged Aβ1–42 evidently
produces a mixture of species of the ﬁnal protein and we relied on
the overabundance of Aβ1–42 to produce some of the most toxic and
relevant forms. Despite literature reports on the detergent properties
of Aβ and the potential deleterious effect of Aβ on synaptic vesicles, we
conclude that in the form and concentration applied, Aβ1–42 does not
affect directly the membrane integrity of synaptic vesicles nor does it
adversely perturb the pumping of protons and neurotransmitters into
the vesicles. Given that Aβ is known to cause synthetic vesicles to have
increased leakage [19,30] and Aβ is thought to attach itself to lipids in
the plasma membrane [20], this result may seem surprising.
To explain this apparent discrepancy, we can look to several im-
portant distinctions between these situations. First, synthetic vesicles
were prepared with Aβ present in the buffer while the synaptic vesi-
cles were not; in our case, vesicles were exposed to Aβ after formation.
Second, the composition of SVs versus synthetic lipid vesicles is very
different. Synthetic vesicles are entirely made of lipid, whereas SVs are
~25% protein [1]. The interior of synthetic vesicles is simply aqueous
solution, but the interior of SVs is a more complicated substance that
behavesmore like a gel [32] and that it is known to contain, at the very
least, glycoside groups from glycosylated proteins in the membrane
[41]. If Aβ must co-form with a membrane in order to permeablize it,
then it would be unlikely to affect SVs in our experimental scenario.
Likewise, given the proportion of membrane and protein, even if Aβ is
capable of attacking in-tact membranes, it may well be that there is
not sufﬁcient bare membrane area on the SV for this to occur in the
same way as synthetic lipid vesicles.
Yang et al. [42] report that incubation of cells with Aβ has dramatic
effects on the intracellular localization of another dye, Lucifer Yellow.
The interpretation was that the impermeability of the lysosome was
compromised. Rodrigues et al. [43] indicate that the mitochondrial
membrane is compromised byAβ. Howmuchof ADpathology is due to
such damage and how much is due to the increased permeability to
calcium of the plasma membrane [44] as occurs in synthetic vesicles
[19] is as yet unclear. The results presented here indicate that some
membranes may be resistant to direct attack, which suggests that ifsynapses malfunction upon exposure to Aβ as is the current view, it
occurs indirectly due to protein–protein interactions, Aβ-lipid inter-
actions on membranes signiﬁcantly different from the membrane of
the SV, or by making a more speciﬁcally permeable portal than can be
detected here. The information gained from the data at the single-
vesicle level indicates no discernible subpopulations of synaptic vesi-
cles or other features indicative of increased leakage that may be
buried under ensemble averaging.We anticipate detailed physical and
biochemical studies of single synaptic vesicles will offer new insight
into themakeup and function of this important and complexorganelle.
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